Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban
Condition(s):Heparin-induced ThrombocytopeniaLast Updated:December 8, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Heparin-induced ThrombocytopeniaLast Updated:December 8, 2022Terminated
Condition(s):Anticoagulation; Venous Thromboembolism; Atrial FibrillationLast Updated:December 1, 2020Unknown status
Condition(s):Acute HIT II (Heparin-induced Thrombocytopenia Type II)Last Updated:July 6, 2017Completed
Condition(s):StrokeLast Updated:July 13, 2018Completed
Condition(s):Dialysis; Complications; Heparin-induced Thrombocytopenia; Chronic Renal FailureLast Updated:October 19, 2022Not yet recruiting
Condition(s):Ischemic StrokeLast Updated:February 17, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.